Skip to main content

Table 1 Comparision of the demographic, socioeconomic, and clinical information between CRRT group and control group

From: Postoperative acute kidney injury requiring continuous renal replacement therapy and outcomes after coronary artery bypass grafting: a nationwide cohort study

Variable

CRRT (n = 214)

Control (n = 14,901)

P-value

Age, year

69.4 (10.6)

65.6 (10.2)

 < 0.001

Sex, Male

124 (57.9)

10,951 (73.5)

 < 0.001

Residence at CABG

  

0.768

 Capital city

45 (21.0)

3399 (22.8)

 

 Other metropolitan city

38 (17.8)

2730 (18.3)

 

 Other area

131 (61.2)

8772 (58.9)

 

Income level at CABG

  

0.073

 Q1

42 (19.6)

2679 (18.0)

 

 Q2

52 (24.3)

3528 (23.7)

 

 Q3

32 (15.0)

3320 (22.3)

 

 Q4

88 (41.1)

5374 (36.1)

 

Charlson comorbidity index at CABG

  

 < 0.001

 0–3

23 (10.7)

3264 (21.9)

 

 4–5

59 (27.6)

4060 (27.2)

 

  ≥ 6

132 (61.7)

7577 (50.8)

 

Intraoperative CPB use

  

 < 0.001

 Off Pump CABG

43 (20.1)

8011 (53.8)

 

 On Pump CABG

171 (79.9)

6890 (46.2)

 

The number of coronary artery graft

  

 < 0.001

 1

51 (23.8)

2405 (16.1)

 

  ≥ 2

163 (76.2)

12,496 (83.9)

 

Total number of hospital bed

  

 < 0.001

 Q1 ≤ 904

65 (30.4)

3723 (25.0)

 

 905 ≤ Q2 ≤ 1119

70 (32.7)

3870 (26.0)

 

 1120 ≤ Q3 ≤ 2413

62 (29.0)

4547 (30.5)

 

 2414 ≤ Q4

17 (7.9)

2761 (18.5)

 

Length of hospital stay for CABG, day

18.0 (10.6)

15.5 (7.9)

 < 0.001

Newly diagnosis of CKD requiring RRT

17 (7.9)

431 (2.9)

 < 0.001

Urgent or Emergency CABG

34 (15.9)

2464 (16.5)

0.800

The year of CABG

  

0.883

 2012

31 (14.5)

2450 (16.4)

 

 2013

29 (13.6)

2183 (14.7)

 

 2014

37 (17.3)

2384 (16.0)

 

 2015

41 (19.2)

2889 (19.4)

 

 2016

45 (21.0)

3168 (21.3)

 

 2017

31 (14.5)

1827 (12.3)

 
  1. CABG coronary artery bypass grafting; CRRT continuous renal replacement therapy; CPB cardiopulmonary bypass; CKD chronic kidney disease; RRT renal replacement therapy